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Abstract 
Purpose Meningiomas in children are rare, especially those located at the skull base. In this 
study, we report our experience of meningioma surgery in the pediatric population and 
compare our findings of skull base (SB) versus non-skull base (NSB) meningiomas.  
Methods From our database of 724 surgically-treated meningioma patients at the University 
Hospital, Zurich between 1995 and 2010, 12 patients under 18 years of age were identified. 
Data for those patients was retrospectively collected through chart review. A descriptive 
comparison betweent SB and NSB meningiomas was undertaken to determine statistical 
significance. 
Results In all 12 children (7 males, 5 females; mean age 12.2 ± 4.3 years) surgical removal of 
the meningioma was performed microsurgically with a mean follow-up of 53 months (range 
12-137 months). Of the 12 tumors, 6 were located in the SB and 6 in the NSB. Comparing SB 
to NSB lesions, the mean age was 11 ± 3.8 years versus 14 ±	  4.6 years; male:female gender 
distribution was  5:1 compared to 1:5, mean tumor size was 7.5 ±	  6.2	  cm2 versus 26 ±	  15.8	  
cm2 (p=0.03) and mean surgery time was 347 minutes versus 214 minutes. Whilst WHO 
grade was similar for both groups, the Simpson grade revealed more extensive resection for 
NSB meningiomas. The Glasgow outcome scale at last follow up was favorable for both 
groups.  
Conclusions Meningioma surgery was safe with favorable outcomes. SB meningiomas were 
significantly smaller in size, were less likely to undergo complete resection and had a 
predilection for younger, male patients. 
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Introduction 
Meningiomas in the pediatric population are rare and represent 0.5-5% of all primary central 
nervous system tumors in children and adolescents (compared to approximately 30% in the 
adult population).[5] An epidemiological study from the Netherlands showed that the overall 
meningioma incidence in children and adolescents is approximately 1: 1,700.000/year.[15] 
Due to the rarity of these lesions, large prospective studies are not available.  By contrast, 
there are a relatively large number of single-center retrospective studies, compromising 5-50 
patients, within the literature.[4, 7, 8, 11-13] A recently published meta-analysis compared for 
the first time the characteristics of nearly 700 pediatric meningiomas from 35 studies.[6] With 
regard to the location of these tumors, the incidence of non-skull base (NSB) meningiomas 
was higher than that of skull base (SB) meningiomas. Approximately 73% were NSB 
meningiomas (convexity, parasagittal, tentorial, intraventricular or intraparenchymal region) 
compared to approximately 27% with a SB location (anterior or middle cranial fossa 
including sphenoid, clinoid, parasellar, olfactory groove meningiomas or petroclival and 
foramen magnum meningiomas).[6] Similar to the adult population, most meningiomas were 
benign (WHO grade I) with 18.8% constituting meningiomas of higher grade (WHO II and 
III).[7] Although SB meningiomas in the adult population are more difficult to treat than NSB 
meningiomas, specific differences between NSB and SB meningiomas in the pediatric 
population have not previously been analyzed.[12, 14] Accordingly, our aim was to determine 
differences between NSB and SB meningiomas in pediatric patients surgically treated at our 
center. 
 
Methods 
From our database of 724 meningioma patients treated at the University Hospital, Zurich 
between 1995 and 2010, we identified patients under 18 years of age at the time of surgery for 
analysis. All patients were operated upon at the Department of Neurosurgery, University 
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Hospital, Zurich and were pre- and postoperatively followed-up at the Department of 
Oncology, Children’s Hospital Zurich. Medical reports, surgical protocols, and 
histopathological reports were reviewed for all patients included in the study. Preoperative 
MRI scans were reported by a senior board-certified neuroradiologist and the greatest cross-
sectional area of the enhancing tumor on T1 sequence was chosen for size analysis. 
A descriptive comparison between SB and NSB menigiomas was undertaken and the Mann-
Whitney U test was used to determine statistical significance. P-values less than 0.05 were 
considered statistically significant. Statistical analyses were performed using SPSS (PASW) 
Version 20.0 (SPSS Inc., Chicago, IL) and Microsoft Excel Version 14.2. 
 
Results  
Twelve patients under 18 years of age (7 males and 5 females) were identified from our 
database (Table 1). The mean age was 12.2 years (SD 4.3, range 4-17 years) and the mean 
follow-up time was 53 months (SD 40, range 12-137). Half of the lesions were located in the  
SB (n=6) and the other half were NSB meningiomas (n=6). SB meningiomas were found at 
the tuberculum sellae (n=4) in the olfactory groove (n=1) and at the sphenoid wing (n=1). The 
NSB meningiomas were located in the parasagittal region (n=4) and in the convexity (n=2). 
Differences between SB versus NSB meningiomas are summarized in Table 2. Although not 
statistically significant, the gender distribution tended toward males in the SB (M:F 5:1) 
compared to NSB (M:F 1:5). The mean age was lower for patients with SB lesions (11years 
(SD 3.4)) compared to those with NSB lesions (14 years (SD 4.6)). In nearly all cases (n=11) 
patients presented clinically with headaches or other signs of increased intracranial pressure 
such as emesis. While every SB meningioma patient (n=6) displayed cranial nerve 
impairment, only 2 patients from the NSB group presented with this clinical features. Paresis 
or seizures occurred in 4 patients with NSB meningiomas while no patient from the SB group 
presented in this way. Preoperative embolization was performed in 3 cases (2 NSB and 1 SB).  
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Two patients had an underlying diagnosis of neurofibromatosis type 2 (both SB 
meningiomas). None of the meningiomas were radiation-induced.  
Preoperative tumor size was significantly smaller in SB compared to NSB meningiomas, with 
a mean size of 7.5cm2 (SD 6.2) versus 26cm2 (SD 15.8), respectively (p=0.03) (Figure 1A). 
Mean surgery time was longer in the SB group: 347 minutes (SD 217) versus 214 minutes 
(SD 49) (p=0.06) (Figure 1B). With regard to the Simpson grade (SG) of surgical resection, 
none of the SB patients had a SG I; 4 patients had a SG II; 1 patient had a SG III; and 1 
patient had a SG IV. As for the NSB group, 3 patients had a SG I; 2 patients had a SG II; and 
1 patient had a SG III and no  patient had a SG IV resection. One NSB meningioma was 
debulked during first surgery and subsequently reoperated on after histologicl examination 
revealed a grade II meningioma. 
Histopathological features were comparable in terms of WHO grade for both groups:  Grade I 
(3 SB and 3 NSB); Grade II (3 SB and 2 NSB); and Grade III (1 NSB) (Table 2). Three 
children received postoperative radiation (gamma knife, n=1; proton radiation, n=2)). The 
outcome was favorable in all patients with no mortality and a Glasgow outcome scale of 4 
(n=3) or 5 (n=9) after the most recent follow-up. Tumor recurrence was seen in 2 cases (both 
parasagittal) and repeat surgeries were performed. No patient developed postoperative 
hydrocephalus.  
 
Discussion  
In this single-center study we compared for the first time surgically resected pediatric 
meningiomas of the SB versus NSB region. The literature suggests that the incidence of 
pediatric meningiomas of the SB is lower than that of the NSB, and that SB meningiomas are 
more difficult to treat clinically.[3, 12, 16]  In our study, however, the distribution was equal, 
with 6 meningiomas located in the SB and 6 in the NSB region. This discrepancy might be 
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due to the small sample size of this study as we analyzed only surgically treated patients 
based on a retrospective single-center analysis.  
Our descriptive review, which compared age and gender distribution, showed a younger, male 
dominance in the SB group versus an older, female dominance in the NSB group. The reasons 
for these age and gender distributions remain unclear. A possible explanation may be the 
influence of puberty on meningioma type.[5, 6] Postpubertal meningiomas are thought to be 
similar to the adult form and a higher proportion occur in female patients.[6] Meningiomas in 
patients under the age of 12 tend to occur more commonly in males, which was confirmed in 
our study. No patient under the age of three was identified inthis study. Meningiomas in this 
age group usually have a worse prognosis when compared to older children due to higher 
operative mortality and morbidity.[6]  
The majority of patients showed signs of increased intracranial pressure at the time of initial 
presentation, and presented with additional clinical symptoms based on the location of their 
mengionomas (Table 1).  
The SB meningiomas were smaller on T1 weighted MRI than NSB meningiomas (p=0.03), 
that significant clinical symptoms are elicited by smaller tumors in the SB compared to NSB 
meningiomas (Figure 1). This difference could be explained by the anatomical proximity of 
the surrounding cranial nerves in the SB region. 
The SG of surgical resection and duration of surgery were more favorable in the NSB group 
than in the SB group, which is similar to results in the adult population.[1, 2] Poor 
accessibility, more complex approach, and dural attachments that cannot be sacrificed, which 
are all characteristic of SB meningiomas, are factors which contribute to this difference.  
Histopathological analysis showed a high ratio (50%) of higher grade meningiomas in both 
groups, including 5 grade II and 1 grade III meningiomas. This result is not concordant with 
the literature, since only a small number of higher grade meningiomas occur in children 
compared to in the adult population.[9] A closer look at the surgical date of our patients 
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revealed that 3 patients were treated before the year 2000 (2 with grade II meningiomas) and 
5 patients were treated between the years 2000 and 2007 (2 with grade II meningiomas). 
Before the year 2007 different versions of the WHO grading system were used to classify 
meningiomas.[10] We suggest that the revisions to the WHO grading system may have 
resulted in upgrading of meningiomas that would have previously considered benign prior to 
the year 2000 and as the majority of the patients in this study were diagnosed after these 
revisions were implicated. [10]  This may subsequently reflect the higher incidence of WHO 
grade II meningiomas. However, due to the retrospective analysis of the data, we were unable 
to confirm this hypothesis since reanalyzing the histological tissue was simply not feasible.  
Our recurrence rate and complication rate was low with two recurrences and one 
postoperative infection. In contrast to the adult population, SB meningiomas did not carry an 
increased risk of hydrocephalus.[1] 
 
Summary 
Meningioma surgery was safe for this pediatric population with favorable clinical outcomes. 
Compared to NSB meningiomas, SB meningiomas were significantly smaller in size, were 
less likely to undergo complete resection and had apredilection for younger, male patients. 
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Figure Legend 
Figure 1 A) Bars with standard deviation to compare mean size of skull base (SB, n=6) 
versus non-skull base (NSB, n=6) meningioma. B) Bars with standard deviations to compare 
mean duration of surgery for SB versus NSB meningioma. 
 
Figure 1 
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Table 1 
Table 1: Summary of pediatric meningioma patients surgically treated in this study 
No   Sex   Age Clinical 
Presentation 
at first 
presentation  
Location Infiltrating 
Tissue 
Preoperative 
Embolization 
Simpson 
Grade 
WHO 
Grade 
/Histol
ogy 
Postop
erative 
Compli
cations 
Adjuvant 
Radiation 
Therapy (dosage) / 
Time between 1st 
surgery and 
radiation (months) 
Recurrency 
/ Resurgery 
(Simpson 
Grade) 
Time of Follow-up 
(months) / Time to 
Recurrency / Time 
between 
Recurrency and 
2nd surgery 
GOS / 
clinical 
symptoms 
at last 
follow-up 
1 M  11  Headache, 
Emesis 
Olfactory 
Groove  
 Bone Yes 3 II / 
atypical 
- No 
 
No / No 16 / - / - 5 / Headache 
2 M  13 Headache, 
Facial Paresis 
Left 
Sphenoid 
Wing 
Bone  No  2 I / 
fibrobla
stic 
- No  No / No 60 / - / - 5 / Headache 
3 M  14 Headache, 
Double Vision  
Tuberculum 
Sellae 
Optic nerve 
compression 
  No 2   II / 
atypical 
Postope
rative 
Wound 
Dehisc
ence  
Gamma knife ( 30.3 
Gy) / 2 
No / No 79 / - / - 4 / 
Headache, 
Double 
Vision 
4 M 8 Headache, 
Double Vision 
Tuberculum 
Sellae 
Optic nerve 
compression 
No 2 I / 
mening
othelial 
- No No / No  137 / - / - 4 / 
Headache, 
Double 
Vision 
5 F 13 Headache Tuberculum 
Sellae 
-  No 2    I / 
mening
othelial 
- No    No / No 12 / - / - 5 / Headache 
6 M 4 Double Vision Tuberculum 
Sellae 
Optic nerve 
compression 
No 4 II /a 
typical 
Tumor 
remnan
t 
Proton Radiation 
(61.2 Gy) / 3  
No / Yes (4) 12 / - / - 5 / Headache 
7 F 13 Headache, left 
Hemiparesis 
Right 
Parietal 
Parasagittal 
Superior 
Sagittal 
Sinus  
No 3  II / 
atypical 
- No  Yes / Yes 
(3) 
93 /  81 / 1 5 / - 
8 M  14 Headache, 
Seizures, 
Hemiparesis 
Left Parietal 
Parasagittal 
Superior 
Sagittal 
Sinus 
No 2 I / 
fibrobla
stic 
- No  Yes / Yes 
(2) 
80 / 46 / 2 5 / - 
9 
 
M 16 Headache, 
Aphasia, 
Dizziness 
Left Parietal 
Parasagittal 
- Yes 1 II / 
atypical 
- No No / No 30 / - 5 / Headache 
10 F  17 Headache Right 
Frontal 
Convexity 
- No  1 I / 
mening
othelial 
- No No / No 34 / - 5 / -  
11  F 17 Headache, 
Double 
Vision, 
Dizziness 
Left Frontal 
Convexity 
-  Yes 2 I / 
mening
othelial 
Epilepti
c 
seizure
s 
No No / No 66 / - 4 / Epileptic 
Seizures, 
Double 
Vision 
12 F 5 Headache, 
Dizziness 
Left Frontal 
Convexity 
- No 1 III / 
anaplas
tic 
- Proton Radiation 
(59.4 Gy) / 2 
No / No 13 / - 5 / - 
	  
M indicates male, F female, WHO World Health Organization, GOS Glasgow Outcome Scale, Gy Gray. 	  
 
 
 
	  	   12	  
Table 2 
Table 2: Comparison of Non-Skull Base versus Skull Base Meningiomas 
   Non-Skull Base (n=6) Skull Base (n=6) 
Gender (m) 1 5 
Age (mean, years) 14 (range 5-17)                    11 (range 4-13)     (p=0.09) 
Clinical presentation 
 Headache, Emesis 
 Seizures 
 Paresis 
Cranial Nerve Symptoms 
 
6 
1 
3 
2 
 
5 
0 
0 
6 
Tumor Size (mean, cm2) 26 (range 6-42)               7.5 (range 2.3-16)    (p=0.03)* 
Preoperative Embolization 2 1               
Surgery Time (mean, minutes) 214 (range 170-300)              347 (range 200-780)   (p=0.06) 
Simpson Grade 
 I 
 II 
 III 
 IV 
 
3 
2 
1 
0 
 
0 
4 
1 
1 
WHO Grade 
 I 
 II 
 III 
 
3 
2 
1 
 
3 
3 
0 
GOS (last follow-up) 
 5 
 4 
 3-1 
 
5 
1 
0 
 
4 
2 
0 	  
m indicates male, WHO World Health Organisation, GOS Glasgow outcome scale. Asterisk statistical significance. 	  
 
 
